Report on consensus meeting of the EORTC melanoma group of educational needs for primary and secondary prevention of melanoma in Europe
Rona M. MacKie(University of Glasgow), C. S. Muir(Scottish Government), Anne Østerlind(IT University of Copenhagen), R Vanwijck(Cliniques Universitaires Saint-Luc), Krzysztof T. Drzewiecki(Rigshospitalet), Peter Fritsch(Austrian Society of Dermatology and Venereology), K.F. Kölmel, Matti Aapro(Clinique de Genolier), J. P. Césarini(Inserm), D. J. Ruiter(Radboud University Nijmegen)
Cited by 22
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|644
Thin Stage I Primary Cutaneous Malignant Melanoma
|New England Journal of Medicine|1988|564